Please login to the form below

Not currently logged in
Email:
Password:

HER2-positive non-small cell lung cancer

This page shows the latest HER2-positive non-small cell lung cancer news and features for those working in and with pharma, biotech and healthcare.

Merck strengthens oncology pipeline with $2.75bn VelosBio deal

Merck strengthens oncology pipeline with $2.75bn VelosBio deal

Merck &Co (MSD) has agreed to acquire VelosBio for $2.75bn, giving MSD access to a number of potential cancer treatments in the process. ... breast cancer (TNBC), hormone receptor-positive and/or HER2-positive breast cancer and non-squamous non-small

Latest news

  • Roche's Kadcyla fails in gastric cancer trial Roche's Kadcyla fails in gastric cancer trial

    The trial is particularly disappointing as Kadcyla parent Herceptin has previously been shown to be effective in HER2-positive gastric cancer, and has been approved for this use for several years. ... expand its use into early breast cancer and is also

  • Avastin approved for cervical cancer in EU Avastin approved for cervical cancer in EU

    Roche's Avastin has added to its long list of approved indications with a green light in the EU to treat cervical cancer. . ... It is also in trials for additional indications including adjuvant treatment of HER2-positive and HER2-negative breast cancer

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics